afcompanies.com

– Stratus, the nation’s leading provider of in-home neurodiagnostic testing services, today announced it will begin actively recruiting military veterans and their spouses through RecruitMilitary, the country’s leading company connecting organization with military-trained talent. With more than 1.4 million registered job seekers, RecruitMilitary is host to the nation’s largest single-source veteran recruitment database and will offer Stratus access to a diverse, highly skilled talent pool. The new relationship with RecruitMilitary will allow qualified veterans, who served as both enlisted members and officers, the opportunity to bring their extensive field experience, training, and impeccable leadership skills to Stratus’ growing team of employees. Stratus is proud to team with RecruitMilitary and to continue its support of military service members by adding qualified veterans to its expanding team of talent.

Once the patient is admitted to the EMU, she would have to submit to everything that often accompanies a hospital stay: IVs, increased risk of infection, cafeteria food, anxiety, and interrupted sleep. Given her circumstances and clinical needs, the patient’s physician reasoned that an ambulatory EEG was the right diagnostic option. This patient was able to have the test done at home, avoiding the EMU wait time and additional travel expenses. While an ambulatory EEG will not always be the right diagnostic for a patient (this is the provider’s discretion), it has been my experience that the burden on the patient is lifted by having their EEG done in-home.

[author_info]Jeremy Slater, M. D., has worked in the field of epilepsy for more than 27 years and currently serves as the Chief Medical Officer for The Alliance Family of Companies. He served as the director of the Texas Comprehensive Epilepsy Program from 2004 through 2017, growing the center from a single neurologist and neurosurgeon to one of the largest epilepsy surgery programs in the country. Dr. Slater earned his medical degree at the University of Pittsburgh School of Medicine, in Pittsburgh, Pa. He completed his residency in neurology followed by a fellowship in epilepsy and clinical neurophysiology at the University of Miami School of Medicine in Miami, Fla.[/author_info]

A large US national health survey by Zack and Luncheon suggests that when compared to the general population, patients with epilepsy have a higher incidence of heart disease, including coronary artery disease, angina pectoris, and myocardial infarction. Pathologic cardiac findings provide further evidence of accelerated heart disease with obstructive coronary artery disease seen in 36% of cases of epilepsy patients with sudden cardiac death, along with other structural changes including myocardial fibrosis, left ventricular hypertrophy, and cardiomegaly. Repolarization abnormalities as measured by T-wave alternans (TWA), a well-established marker of risk for lethal arrhythmias leading to sudden cardiac death in the cardiac population, offers a window onto arrhythmogenic risk in patients with epilepsy. We recommend a determination of risk for sudden cardiac death with routine 12-lead EKG recordings, and in select cases, multi-day ambulatory EKG monitoring using cardiac patches, as well as full cardiologic evaluation for patients in the highest category of cardiac risk for sudden cardiac death.